The board of directors of Grifols will vote at its ordinary general meeting of shareholders, scheduled for June 5 in a second call, a long-term variable remuneration plan based on the delivery of shares for members of the senior management team and other key employees of the plasma-derived company and its subsidiaries, whose maximum total amount allocated has been set at 9.3 million euros.

FUENTE

Por Redaccion

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *